3 unknown, 1 completed. 3 Early Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Unknown 2, Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Losartan potassium 50mg: new trials by email Literature Review of Losartan potassium 50mg trials Research Report on Losartan potassium 50mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Losartan and Social Processing Losartan potassium 50mg, Placebo - Social Cognition | Early Phase 1 | Completed | University of Oxford | 68 | 2024-08-19 | 2026-09-24 |
| Losartan and Emotional Learning Losartan potassium 50mg, Placebo - Emotional Processing | Early Phase 1 | Unknown | University of Oxford | 60 | 2024-08-14 | 2024-10-04 |
| Matão Controlling Hypertension (MatCH Study): Rationale and Design Captopril 25Mg, Hydrochlorothiazide 25Mg Oral Tablet,, Atenolol, Losartan potassium 50mg - Hypertension, Blood Pressure | Early Phase 1 | Unknown | Centro Neurológico de Pesquisa e Reabiitação, Brazil | 15000 | 2018-02-01 | 2017-11-21 |
| Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis Shenyankangfu tablets, Losartan potassium 50mg, Shenyankangfu tablets and Losartan potassium 50mg - Glomerulonephritis, Proteinuria | Phase 4 | Unknown | Chinese PLA General Hospital | 720 | 2014-02-01 | 2015-07-01 |
Anxiety Disorders (1) · Depression (1) · Glomerulonephritis (1) · Hypertension (1) · Proteinuria (1)
University of Oxford (2) · Centro Neurológico de Pesquisa e Reabiitação, Brazil (1) · Chinese PLA General Hospital (1)
United Kingdom (2) · China (1)
Andrea Reinecke, PhD (1) · Cesar Minelli, MD, PhD (1)
PMID 22157565, PMID 25480673, PMID 25926990, PMID 26039598, PMID 26811272, PMID 27298661, PMID 27819381, PMID 27819386, PMID 33589406, PMID 42745010